Fed Regist. 2012 Nov 16;77(222):68891-9373.
This major final rule with comment period addresses changes to the physician fee schedule, payments for Part B drugs, and other Medicare Part B payment policies to ensure that our payment systems are updated to reflect changes in medical practice and the relative value of services. It also implements provisions of the Affordable Care Act by establishing a face-to-face encounter as a condition of payment for certain durable medical equipment (DME) items. In addition, it implements statutory changes regarding the termination of non-random prepayment review. This final rule with comment period also includes a discussion in the Supplementary Information regarding various programs . (See the Table of Contents for a listing of the specific issues addressed in this final rule with comment period.)
本带有意见征求期的主要最终规则涉及医师费率表的变更、B 部分药品的支付、以及其他医疗保险 B 部分支付政策,以确保我们的支付系统得到更新,以反映医疗实践的变化和服务的相对价值。它还通过规定面对面会诊作为某些耐用医疗设备(DME)项目支付的条件来实施《平价医疗法案》的条款。此外,它实施了关于终止非随机预付款审查的法定变更。本带有意见征求期的最终规则还在补充信息中对各种项目进行了讨论。(有关本带有意见征求期的最终规则所涉及的具体问题清单,请参阅目录。)